Arabesque Asset Management LTD Regeneron Pharmaceuticals, Inc. Transaction History

Arabesque Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.32 Million - $1.43 Million	1,864 Added 55.89%	5,199 $3.75 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $212,759 - $286,669	388 Added 13.17%	3,335 $1.97 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1.75 Million - $2.06 Million	2,947 New	2,947 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1.8 Million - $2.22 Million	-3,306 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.9 Million - $2.25 Million	3,306 New	3,306 $2 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $2.78 Million - $3.36 Million	-5,102 Closed	0 $0
Q2 2020 Oct 22, 2020	BUY	$493.32 - $643.92 $2.52 Million - $3.29 Million	5,102 New	5,102 $3.18 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.